321 related articles for article (PubMed ID: 31735515)
21. Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.
He J; Zhang X; Wei Y; Sun X; Chen Y; Deng J; Jin Y; Gan Y; Hu X; Jia R; Xu C; Hou Z; Leong YA; Zhu L; Feng J; An Y; Jia Y; Li C; Liu X; Ye H; Ren L; Li R; Yao H; Li Y; Chen S; Zhang X; Su Y; Guo J; Shen N; Morand EF; Yu D; Li Z
Nat Med; 2016 Sep; 22(9):991-3. PubMed ID: 27500725
[TBL] [Abstract][Full Text] [Related]
22. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.
Shivakumar S; Tsokos GC; Datta SK
J Immunol; 1989 Jul; 143(1):103-12. PubMed ID: 2525144
[TBL] [Abstract][Full Text] [Related]
23. Concomitant use of interleukin-2 and tacrolimus suppresses follicular helper T cell proportion and exerts therapeutic effect against lupus nephritis in systemic lupus erythematosus-like chronic graft versus host disease.
Nasa Y; Satake A; Tsuji R; Saito R; Tsubokura Y; Yoshimura H; Ito T
Front Immunol; 2024; 15():1326066. PubMed ID: 38665907
[TBL] [Abstract][Full Text] [Related]
24. Follicular helper T cells in immunity and systemic autoimmunity.
Craft JE
Nat Rev Rheumatol; 2012 May; 8(6):337-47. PubMed ID: 22549246
[TBL] [Abstract][Full Text] [Related]
25. Type I Interferon-Activated STAT4 Regulation of Follicular Helper T Cell-Dependent Cytokine and Immunoglobulin Production in Lupus.
Dong X; Antao OQ; Song W; Sanchez GM; Zembrzuski K; Koumpouras F; Lemenze A; Craft J; Weinstein JS
Arthritis Rheumatol; 2021 Mar; 73(3):478-489. PubMed ID: 33512094
[TBL] [Abstract][Full Text] [Related]
26. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
[TBL] [Abstract][Full Text] [Related]
27. PD-L1- and IL-4-expressing basophils promote pathogenic accumulation of T follicular helper cells in lupus.
Tchen J; Simon Q; Chapart L; Thaminy MK; Vibhushan S; Saveanu L; Lamri Y; Saidoune F; Pacreau E; Pellefigues C; Bex-Coudrat J; Karasuyama H; Miyake K; Hidalgo J; Fallon PG; Papo T; Blank U; Benhamou M; Hanouna G; Sacre K; Daugas E; Charles N
Nat Commun; 2024 Apr; 15(1):3389. PubMed ID: 38649353
[TBL] [Abstract][Full Text] [Related]
28. Follicular helper T cells in systemic lupus erythematosus: a potential therapeutic target.
Dong W; Zhu P; Wang Y; Wang Z
Autoimmun Rev; 2011 Apr; 10(6):299-304. PubMed ID: 21111068
[TBL] [Abstract][Full Text] [Related]
29. The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer.
Geginat J; Larghi P; Paroni M; Nizzoli G; Penatti A; Pagani M; Gagliani N; Meroni P; Abrignani S; Flavell RA
Cytokine Growth Factor Rev; 2016 Aug; 30():87-93. PubMed ID: 26980675
[TBL] [Abstract][Full Text] [Related]
30. The pathology of T cells in systemic lupus erythematosus.
Mak A; Kow NY
J Immunol Res; 2014; 2014():419029. PubMed ID: 24864268
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis.
al-Janadi M; al-Dalaan A; al-Balla S; al-Humaidi M; Raziuddin S
J Clin Immunol; 1996 Jul; 16(4):198-207. PubMed ID: 8840221
[TBL] [Abstract][Full Text] [Related]
32. T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus.
Yang X; Yang J; Chu Y; Xue Y; Xuan D; Zheng S; Zou H
PLoS One; 2014; 9(2):e88441. PubMed ID: 24551101
[TBL] [Abstract][Full Text] [Related]
33. T cell subsets in patients with systemic lupus erythematosus.
Kucharz EJ; Sierakowski SJ
Med Interne; 1988; 26(3):227-33. PubMed ID: 2973120
[TBL] [Abstract][Full Text] [Related]
34. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
35. Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus.
Gao N; Dresel J; Eckstein V; Gellert R; Störch H; Venigalla RK; Schwenger V; Max R; Blank N; Lorenz HM; Tretter T
Arthritis Rheumatol; 2014 Oct; 66(10):2849-61. PubMed ID: 24942956
[TBL] [Abstract][Full Text] [Related]
36. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus.
Cross JT; Benton HP
Inflamm Res; 1999 May; 48(5):255-61. PubMed ID: 10391113
[TBL] [Abstract][Full Text] [Related]
37. Cellular DNA content of T helper, T suppressor and B lymphocytes in SLE.
Surányi P; Mátyus L; Sonkoly I; Szegedi G
Clin Exp Immunol; 1984 Oct; 58(1):37-41. PubMed ID: 6236918
[TBL] [Abstract][Full Text] [Related]
38. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
39. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
40. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
Mohan C; Adams S; Stanik V; Datta SK
J Exp Med; 1993 May; 177(5):1367-81. PubMed ID: 8478612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
